Development of novel agonists for the orphan nuclear receptor, Nurr1 : a therapeutic strategy for Parkinson’s disease
Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disease among the elderly. It is characterized pathologically by the demise of dopaminergic (DA) neurons in the substantia nigra region of the midbrain resulting in the loss of motor function. The orphan nuclear receptor, Nurr1,...
Main Author: | Toh, Hui Ting |
---|---|
Other Authors: | Liu Xuewei |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/89266 http://hdl.handle.net/10220/48045 |
Similar Items
-
Characterization of novel neuroprotective ligands modulating molecular behavior of alpha synuclein in Parkinson's disease
by: Toh, Hui Ting
Published: (2014) -
Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
by: Park, Tae-Yoon, et al.
Published: (2020) -
Characterisation of RIG-I-like receptor agonists for dengue virus therapy or vaccination
by: Ho, Victor Chin Yong
Published: (2019) -
Novel inverse agonists for the orphan G protein-coupled receptor 6
by: Alyssa S. Laun, et al.
Published: (2018-11-01) -
Prostaglandin A2 interacts with Nurr1 and ameliorates behavioral deficits in Parkinson's disease fly model
by: Rajan, Sreekanth, et al.
Published: (2022)